Literature DB >> 12938024

Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease.

R I Westphalen1, H L Scott, P R Dodd.   

Abstract

The apparent l-[3H]glutamate uptake rate (v') was measured in synaptic vesicles isolated from cerebral cortex synaptosomes prepared from autopsied Alzheimer and non-Alzheimer dementia cases, and age-matched controls. The initial synaptosome preparations exhibited similar densities of d-[3H]aspartate membrane binding sites (BMAX values) in the three groups. In control brain the temporal cortex d-[3H]aspartate BMAX was 132% of that in motor cortex, parallel with the l-[3H]glutamate v' values (temporal=139% of motor; NS). Unlike d-[3H]aspartate BMAX values, l-[3H]glutamate v' values were markedly and selectively lower in Alzheimer brain preparations than in controls, particularly in temporal cortex. The difference could not be attributed to differential effects of autopsy interval or age at death. Non-Alzheimer dementia cases resembled controls. The selective loss of vesicular glutamate transport is consistent with a dysfunction in the recycling of transmitter glutamate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938024     DOI: 10.1007/s00702-003-0012-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  7 in total

1.  Electrically evoked synaptosomal amino acid transmitter release in human brain in alcohol misuse.

Authors:  Sheng-Wen Kuo; Peter R Dodd
Journal:  Neurosignals       Date:  2011-08-11

2.  Pharmacological and genetic reversal of age-dependent cognitive deficits attributable to decreased presenilin function.

Authors:  Sean M J McBride; Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; David A Liebelt; David Ferreiro; Richard J Choi; Paul Hinchey; Maria Kollaros; Allison M Terlizzi; Neal J Ferrick; Eric Koenigsberg; Rebecca L Rudominer; Ai Sumida; Stephanie Chiorean; Kathleen K Siwicki; Hanh T Nguyen; Mark E Fortini; Thomas V McDonald; Thomas A Jongens
Journal:  J Neurosci       Date:  2010-07-14       Impact factor: 6.167

Review 3.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 4.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

5.  Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers.

Authors:  Aida Attar; Cristian Ripoli; Elisa Riccardi; Panchanan Maiti; Domenica D Li Puma; Tingyu Liu; Jane Hayes; Mychica R Jones; Kristin Lichti-Kaiser; Fusheng Yang; Greg D Gale; Chi-Hong Tseng; Miao Tan; Cui-Wei Xie; Jeffrey L Straudinger; Frank-Gerrit Klärner; Thomas Schrader; Sally A Frautschy; Claudio Grassi; Gal Bitan
Journal:  Brain       Date:  2012-11-26       Impact factor: 13.501

6.  Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil.

Authors:  D Béracochéa; J N Philippin; S Meunier; P Morain; K Bernard
Journal:  Psychopharmacology (Berl)       Date:  2007-03-24       Impact factor: 4.415

7.  Chemical Stimulation of Rodent and Human Cortical Synaptosomes: Implications in Neurodegeneration.

Authors:  Faraz Ahmad; Yu Jing; Albert Lladó; Ping Liu
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.